The spin-off of the life sciences of Alphabet, Verily, and Colgate-Palmolive are launch a study to investigate the link between oral health and cardiometabolic health. The companies plan to enroll 200 participants in the Verily Benchmark Health Study, a comprehensive study collecting data from thousands of volunteer patients.
Participants will be divided equally into a control group and an intervention group. Both will receive an initial deep cleaning at the University of North Carolina School of Dentistry at Chapel Hill Adams. Over an 18-month period, patients in the intervention group will use dental irrigation and a Colgate smart toothbrush, while the control group will not receive any additional equipment during the study.
Ultimately, participants will be screened for changes in their oral health, blood sugar, and flow-mediated dilation, a measure of how much an artery dilates when blood flow increases.
The goal is to see if improving people’s oral health improves their overall health.
“We have known for some time that oral health, cardiovascular disease and diabetes are interrelated. The depth of biological measurement in the Baseline Health Study combined with the dental expertise of the UNC Adams and Colgate School of Dentistry will allow us to expand our knowledge base dramatically, ”said Dr. Rob Califf, Chief Clinical Policy Officer from Verily and Google Health, it said in a press release.
The partnership is just one part of Verily’s broader effort to build its research platforms. The company Amy Abernethy recently hired, former acting CIO of the Food and Drug Administration, as president of its clinical research business.